Drug
Gp2013
Gp2013: highest development phase Phase 3, developed by Sandoz. 3 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Sandoz
Trials
| Drug | Phase | Indication |
|---|---|---|
| GP2013 NCT01419665 | Phase 3 | Follicular Lymphoma |
| GP2013 NCT01274182 | Phase 1/2 | Rheumatoid Arthritis |
| GP2013 NCT01933516 | Phase 1 | Indolent B-cell Non-Hodgkin's Lymphoma |
Latest
No recent events.
Follow Gp2013 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.